Understanding and predicting venous thromboembolism: The role of coagulation factors and inflammatory markers

American Journal of Medicine

Volumn 113, Issue 8, 2002, Pages 689-690

  Dowling, Nicole F ^a,c   Hooper, W Craig ^a   Austin, Harland ^b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT PROTEIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; FIBRINOGEN; HORMONE; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTHROMBIN; VON WILLEBRAND FACTOR;

ANTICOAGULATION; BLOOD CLOTTING; CANCER; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE MARKER; EDITORIAL; GENETIC ANALYSIS; GENETIC RISK; HEREDITY; HUMAN; HYPERCOAGULABILITY; IMMOBILIZATION; INFLAMMATION; INJURY; LEUKOCYTE COUNT; LIFESTYLE; LUNG EMBOLISM; PATHOGENESIS; POSTOPERATIVE COMPLICATION; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; THROMBOEMBOLISM; UNITED STATES; VENOUS INFLAMMATION;

BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; FEMALE; HUMANS; INCIDENCE; INFLAMMATION MEDIATORS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; VENOUS THROMBOSIS;

EID: 0036917155     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01395-5     Document Type: Editorial

References (14)

1. Heit J.A., Silverstein M.D., Mohr D.N., et al. Predictors of survival after deep vein thrombosis and pulmonary embolism a population-based cohort study. Arch Intern Med. 159:1999;445-453.
2. Heijboer H., Brandjes D.P., Buller H.R., et al. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med. 323:1990;1512-1516.
3. Rosendaal F.R. Venous thrombosis a multicausal disease. Lancet. 353:1999;1167-1173.
4. Tsai A.W., Cushman M., Rosamond W.D., et al. Coagulation factors, inflammation markers, and venous thromboembolism incidence the Longitudinal Investigation of Thromboembolism Etiology (LITE). Am J Med. 113:2002;636-642.
5. Koster T., Blann A.D., Briet E., et al. Role of clotting factor VIII in effect on von Willebrand factor on occurrence of deep vein thrombosis. Lancet. 345:1995;152-155.
6. Kraaijenhagen R.A., in't Anker P.S., Koopman M.M., et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost. 83:2000;5-9.
7. Kamphuisen P.W., Eikenboom J.C., Vos H.L., et al. Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions. Thromb Haemost. 81:1999;680-683.
8. O'Donnell J., Mumford A.D., Manning R.A., et al. Elevation of FVIII:C in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemost. 83:2000;10-13.
9. Kyrle P.A., Minar E., Hirschl M., et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med. 343:2000;457-462.
10. O'Donnell J., Mumford A.D., Manning R.A., et al. Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism. Br J Haemotol. 115:2001;687-691.
11. Van Aken B.E., den Heijer M., Bos G.M.J., et al. Recurrent venous thrombosis and markers of inflammation. Thromb Haemost. 83:2000;536-539.
12. Van Aken B.E., Reitsma P.H., Rosendaal F.R. Interleukin 8 and venous thrombosis evidence for a role of inflammation in thrombosis. Br J Haemotol. 116:2002;173-177.
13. Cermak J., Key N.S., Bach R.R., et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 82:1993;513-520.
14. Lowe G., Rumley A., Woodward M., et al. C-reactive protein, idiopathic venous thromboembolism and hormone replacement therapy. Thromb Haemost. 84:2000;730-731.